FBRX 株価推移チャート
FBRX 収入
Forte Biosciences Inc
$35.09
3.51%
$1.19
終値： Apr 10, 16:00:00 GMT-4
$34.05
-2.96%
$-1.04
アフターマーケット：Apr 10, 20:00:00 GMT-4
戻る
Forte Biosciences Inc (FBRX) 収入
主要データ
前終値
$33.9
始値
$34.06
当日レンジ
$32.46 - $35.3
52週レンジ
$4.9 - $35.8
取引高
705.3K
平均取引高
269.1K
配当利回り
--
1株当たり利益(TTM)
-4.49
時価総額
$426.6M
FBRXとは何ですか？
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The company is headquartered in Dallas, Texas and currently employs 16 full-time employees. The company went IPO on 2017-04-13. The company is advancing clinical development of FB102 into patient-based trials for celiac disease and non-segmental vitiligo. The firm's FB102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and certain T cell subsets. FB102 has potentially other autoimmune and autoimmune-related applications including vitiligo, alopecia areata, and type 1 diabetes (T1D). Its subsidiaries include Forte Subsidiary, Inc. and Forte Biosciences Australia Proprietary Limited.